| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |